Update on impacts from COVID-19 on the Takeda Supply Chain in Australia and New Zealand

Update on impacts from COVID-19 on the Takeda Supply Chain in Australia and New Zealand 17/03/2020 1:15pm

In light of the current Covid-19 situation HFNZ have sought assurances from suppliers of treatment products

At this stage the global supply network for Takeda is reporting no disruption and no shipments blocked for Australia or New Zealand. Cargo shipments are not currently blocked by the various international passenger restrictions and although there are some delays in booking cargo space with fewer flights operating, we have multiple routes available so we do not anticipate supply shortages at this stage. 

Got some questions about Haemophilia?
Check out our FAQ's page